Search results

Articles (5)

Journals (0)

1-5 of 5 results for LIBRETTO-321

Sort by:

Relevance

Select all

Sort by:

Relevance

Open access

Research article

First published 2023

Patient-reported outcomes following selpercatinib treatment in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer and thyroid cancer,and RET -mutant medullary thyroid cancer in the phase II LIBRETTO-321 trial

Shun Lu, Xiangqian Zheng, Yuping Sun [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

Efficacy and safety of selpercatinib in Chinese patients with advanced RET -altered thyroid cancers: results from the phase II LIBRETTO-321 study

Xiangqian Zheng, Qinghai Ji, Yuping Sun [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Selpercatinib in Chinese patients with RET -fusion-positive non-small-cell lung cancer: updated efficacy and safety analysis from the LIBRETTO-321 phase II trial

Shun Lu, Ying Cheng, Dingzhi Huang [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

Efficacy and safety of selpercatinib in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321)

Shun Lu, Ying Cheng, Dingzhi Huang [...]

Therapeutic Advances in Medical Oncology

Open access

Correction

First published 2025

Corrigendum to “Selpercatinib in Chinese patients with RET -fusion-positive non-small-cell lung cancer: updated efficacy and safety analysis from the LIBRETTO-321 phase II trial”

Therapeutic Advances in Medical Oncology